New collaborative research led by Roswell Park shows that treatment with immune checkpoint inhibitors (ICIs) has led to a significant improvement in survival and response rates among patients with a particularly aggressive type of kidney cancer: advanced sarcomatoid renal cell carcinoma. The study is detailed in a presentation at the ASCO 2021 virtual annual meeting.

A pain-management protocol designed by Emese Zsiros, MD, PhD, FACOG, reported at the American Society of Clinical Oncology 2021 virtual annual meeting, resulted in a 45% decrease in the amount of opioids prescribed to patients undergoing surgery, without any significant effect on patient recovery or satisfaction.

The joint Roswell Park/Kaiser Permanente Northern California team behind a new study to be highlighted at the American Society of Clinical Oncology 2021 virtual annual meeting has found that sufficient vitamin D levels at the time of diagnosis are associated with improved outcomes among people with breast cancer.

At the American Society of Clinical Oncology 2021 virtual Annual Meeting, Roswell Park teams will share new data and insights on topics ranging from reducing use of opioids to manage patients’ pain following surgery to an analysis of trends in response to cancer treatment among patients of different races.

A veteran diagnostic radiologist and nuclear physician, Roswell Park Comprehensive Cancer Center’s Alan Klitzke, MD, FACNM, has been named a Fellow of the American College of Radiology (ACR).